| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |